NEW DELHI: Ambarish Mitra, co-founder and CEO of augmented reality and computer vision based AI application platform Blippar, announced on Tuesday that he is leading a consortium that is investing in Global Gene Corp – a Cambridge UK based genomics data platform that is looking to “democratise precision healthcare.”
Mitra believes Global Gene Corp – valued at US$36.9 million at the time of the investment – is at the cusp of taking precision medicine to the masses by understanding the function of genomes. “Global Gene Corp sits at the convergence point of genomic and life sciences, machine learning and big data technologies,” he said. “They have fundamentally disrupted the business model to deliver a platform that is scalable and affordable.” Global Gene Corp’s R&D center is based at the Wellcome Genome Campus, Cambridge (UK). It gains to seek insights through the study of genomes to help scientists better understand disease and then develop more effective drug delivery systems and therapeutics.
Source: The Times of India